FR2789312B1 - STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS - Google Patents

STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS

Info

Publication number
FR2789312B1
FR2789312B1 FR9901342A FR9901342A FR2789312B1 FR 2789312 B1 FR2789312 B1 FR 2789312B1 FR 9901342 A FR9901342 A FR 9901342A FR 9901342 A FR9901342 A FR 9901342A FR 2789312 B1 FR2789312 B1 FR 2789312B1
Authority
FR
France
Prior art keywords
sulphates
sterol
cosmetic
applications
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9901342A
Other languages
French (fr)
Other versions
FR2789312A1 (en
Inventor
Dominique Peyronel
Farra Daniel Dal
Joel Mantelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SEPORGA
Original Assignee
SEPORGA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SEPORGA filed Critical SEPORGA
Priority to FR9901342A priority Critical patent/FR2789312B1/en
Publication of FR2789312A1 publication Critical patent/FR2789312A1/en
Application granted granted Critical
Publication of FR2789312B1 publication Critical patent/FR2789312B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
FR9901342A 1999-02-05 1999-02-05 STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS Expired - Lifetime FR2789312B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9901342A FR2789312B1 (en) 1999-02-05 1999-02-05 STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901342A FR2789312B1 (en) 1999-02-05 1999-02-05 STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS

Publications (2)

Publication Number Publication Date
FR2789312A1 FR2789312A1 (en) 2000-08-11
FR2789312B1 true FR2789312B1 (en) 2003-10-17

Family

ID=9541639

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9901342A Expired - Lifetime FR2789312B1 (en) 1999-02-05 1999-02-05 STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS

Country Status (1)

Country Link
FR (1) FR2789312B1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005220043A (en) * 2004-02-04 2005-08-18 Kanebo Cosmetics Inc Wrinkle improving agent
FR2940126B1 (en) 2008-12-23 2013-05-10 Isp Investments Inc COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE
FR2940292B1 (en) 2008-12-23 2013-05-10 Isp Investments Inc PEPTIDES DERIVED FROM HMG-COA REDUCTASE AND COSMETIC AND / OR PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2940125B1 (en) 2008-12-23 2013-03-22 Isp Investments Inc COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE
FR2940291B1 (en) 2008-12-23 2012-12-21 Isp Investments Inc PEPTIDE DERIVED FROM HMG-COA REDUCTASE AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
FR2944526B1 (en) 2009-04-15 2013-05-10 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE HYDROLYZATE CAPABLE OF STRENGTHENING BARRIER FUNCTION
FR2944445B1 (en) 2009-04-15 2013-08-16 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A SOOTHING PEPTIDE HYDROLYZATE
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871974T2 (en) * 1987-02-12 1993-01-14 Estee Lauder Inc HAIR PROTECTIVE AGENT AND METHOD.
JPH01305014A (en) * 1988-06-01 1989-12-08 Pola Chem Ind Inc Manicure
ATE275957T1 (en) * 1993-01-19 2004-10-15 Endorech Inc THERAPEUTIC USES AND ADMINISTRATION SYSTEMS OF DEHYDROEPIANDROSTERONE
FR2729854A1 (en) * 1995-01-26 1996-08-02 Oreal USE OF DEHYDROEPI-ANDROSTERONE SULFATE IN A COSMETIC OR DERMATOLOGICAL COMPOSITION
DE19642874C1 (en) * 1996-10-17 1998-05-07 Henkel Kgaa Deodorising preparations
DE19642872C1 (en) * 1996-10-17 1998-02-12 Henkel Kgaa Use of sterol sulphate compounds to inhibit serine protease
DE19642875B4 (en) * 1996-10-17 2004-08-26 Cognis Deutschland Gmbh & Co. Kg Process for the production of sterol sulfates

Also Published As

Publication number Publication date
FR2789312A1 (en) 2000-08-11

Similar Documents

Publication Publication Date Title
DE50105387D1 (en) ELECTROLYTE COSMETIC, PHARMACEUTICAL AND DERMATOLOGICAL AGENTS
BR0115810B1 (en) surfactant-free cosmetic, dermatological and pharmaceutical compositions.
DK1095016T3 (en) Sulfur-substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical compositions comprising them
DE50211581D1 (en) Surfactant-free cosmetic, dermatological and pharmaceutical agents
DE60106275D1 (en) DERMATOLOGICAL AGENT
CY2013032I2 (en) EXENDINE-4 CONJUGATE AND THEIR PHARMACEUTICAL USE
ATE247489T1 (en) MEDICINAL PRODUCTS CONTAINING A BASIC ACTIVE INGREDIENT, A CYCLODEXTRIN, A POLYMER AND AN ACID
DE59904724D1 (en) LIPID-REDUCED, FLOWABLE COSMETIC OR DERMATOLOGICAL PREPARATIONS
FR2834718B1 (en) COSMETIC AND / OR PHARMACEUTICAL ACTIVE SUBSTANCES
DE69601755D1 (en) Stable composition that contains a water-sensitive cosmetic and / or dermatological active ingredient
AU2002215325A1 (en) Scalp cosmetic and dermatological compositions
DE69600065D1 (en) Dermatological and / or pharmaceutical preparation, its manufacture and use
ID22565A (en) USE OF NANODISPERION IN FINAL DRUG FORMULATION
LV12624A (en) Thienylazolylalcoxyethanamines their preparation and their application as medicaments
BR0112962B1 (en) Pharmaceutical compositions comprising hyaluronic acid, glycyrretinic acid and polyvinylpyrrolidone, and their use in the preparation of medicaments.
DE60003938D1 (en) ACTIVE INGREDIENTS IN HYDROGEL MICROPearlS
EE05000B1 (en) 2'-Substituted 1,1'-biphenyl-2-carboxamides, their use and pharmaceutical preparations
PT1230230E (en) DERIVATIVES OF INDENO-DI-HYDROTIAZOLE AND ITS PREPARATION AND ITS USE AS ANOREXIGENIC MEDICINES
AU5979100A (en) Two-phase hair or skin care agent containing perfume
FR2789312B1 (en) STEROL 3 SULPHATES, NEW ACTIVE INGREDIENTS FOR COSMETIC AND DERMATOLOGICAL USE, AND THEIR APPLICATIONS
ITMI20011022A0 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS AGAINST SKIN AGING
NO20022022L (en) N-guanidinoalkylamides, their preparation, their use and pharmaceutical compositions comprising these
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
FR2805461B1 (en) NEW SKIN SCRUBING AGENTS AND NEW COSMETIC COMPOSITIONS
WO2003011241A8 (en) Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20